Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?
- PMID: 12586789
- DOI: 10.1200/JCO.2003.10.086
Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?
Comment on
-
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).J Clin Oncol. 2003 Feb 15;21(4):588-92. doi: 10.1200/JCO.2003.08.013. J Clin Oncol. 2003. PMID: 12586793 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
